Examining Misaligned Incentives for Payers and Manufacturers in Value-Based Pharmaceutical Contracts-Reference-Cited by-同舟云学术

Examining Misaligned Incentives for Payers and Manufacturers in Value-Based Pharmaceutical Contracts

Published:2020-01 Issue:1 Volume:26 Page:63-66
ISSN:2376-0540
Container-title:Journal of Managed Care & Specialty Pharmacy
language:en
Short-container-title:JMCP

Author:

Kannarkat Joseph T.¹,Good Chester B.²,Kelly Erin³,Parekh Natasha²

Affiliation:

1. Department of Politics and International Studies, University of Cambridge, United Kingdom.

2. UPMC Centers for Value-Based Pharmacy Initiatives and High-Value Health Care, UPMC Insurance Services Division, and University of Pittsburgh Division of General Internal Medicine, Pittsburgh, Pennsylvania.

3. University of Pittsburgh Division of General Internal Medicine, Pittsburgh, Pennsylvania.

Publisher

Academy of Managed Care Pharmacy

Subject

Health Policy,Pharmaceutical Science,Pharmacy

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing Access to Cell and Gene Therapies in Medicaid;JAMA;2024-06-18

2. Towards a process framework to guide the development of outcome-based models in a healthcare context;2023 IEEE International Conference on Technology Management, Operations and Decisions (ICTMOD);2023-11-22

3. Ready for risk sharing? Performance-based agreements as a catalyst of innovative pharmacotherapy;Polish Journal of Political Science;2023

4. A Scoping Review Investigating the Use of Outcome-based Models to Improve Healthcare Outcomes and Reduce Healthcare Spending;2022 IEEE International Conference on Industrial Engineering and Engineering Management (IEEM);2022-12-07

5. A quantitative analysis of risk-sharing agreements with patient support programs for improving medication adherence;Health Care Management Science;2021-11-30